About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,885 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,885 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1981-2000 of 10,885 trials

TerminatedA Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal ImpairmentThis study evaluates the safety and efficacy of lesinurad administered with an XOI versus a placebo plus an XOI in gout participants who have moderate renal impairment and who are…NCT03226899·Birmingham, Alabama and 115 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedPhase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) MutationThe primary objectives of Phase 1 Dose Escalation/Part 1 Expansion are: * To assess the safety and tolerability of treatment with enasidenib administered continuously as a single…NCT01915498·Duarte, California and 23 others

WithdrawnNeuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke PatientsDevelop and quantify methods for evaluating bladder dysfunction in diabetes and strokeNCT00713921·Nashville, Tennessee

CompletedLight Therapy for PD - Dose SelectionThis study aims to determine the most effective dose of light therapy to improve sleep in people with Parkinson's Disease.NCT04291014·Birmingham, Alabama and 24 others

Completed5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal CancerThis phase II trial will investigate the combination of adjuvant 5-fluorouracil, radiation, and bevacizumab in patients with stage II and III rectal cancer, followed by FOLFOX6…NCT00308516·Anniston, Alabama and 13 others

CompletedStudy of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsThis study will look at the safety of substituting exenatide for insulin in patients with type 2 diabetes who are currently taking insulin and oral antidiabetic agent(s).NCT00099333·Chula Vista, California and 4 others

TerminatedAn Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local…NCT02316847·Phoenix, Arizona and 32 others

RecruitingA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or…NCT04913285·Los Angeles, California and 47 others

Active not recruitingPhase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerThis is a Phase 1b open-label, 2-part study in 4 treatment groups.NCT05508906·Gilbert, Arizona and 15 others

CompletedA Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fraction (HFrEF), specifically…NCT05093933·Alexander City, Alabama and 518 others

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

TerminatedTiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyTiTAN-1 is a first-in-human study of GEN-011, an experimental treatment being evaluated in adult patients with advanced cancer.NCT04596033·Gilbert, Arizona and 7 others

UnknownPhase I Study of Pyrotinib in Patients With HER2-positive Solid TumorsPart 1: to assess the safety and tolerability of pyrotinib and to define the maximum tolerated dose (MTD) of pyrotinib in patients with Human Epidermal Growth Factor Receptor 2…NCT02500199·Orange, California and 9 others

CompletedThe Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCTThis multi-center study will enroll Adult subjects diagnosed with neo-vascular age-related macular degeneration (NV-AMD) in at least one eye at the time of enrollment. the subject…NCT05202587·Lakewood, Colorado and 4 others

CompletedEvaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent SubjectsThe objective of this study is to characterize the pharmacokinetics and to evaluate the safety of single and multiple doses of Oxycodone Oral Solution in pediatric and adolescent…NCT01959204·Orange, California and 8 others

TerminatedFilgotinib in Long-Term Extension Study of Adults With Crohn's DiseaseThe primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a…NCT02914600·Dothan, Alabama and 485 others

CompletedA Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's LymphomaThe purpose of this study is to assess the feasibility, efficacy and safety of adding bevacizumab to rituximab compared to rituximab alone in patients with previously treated…NCT00193492·Jonesboro, Arkansas and 21 others

TerminatedPlacebo Controlled Study of VS-6063 in Subjects With Malignant Pleural MesotheliomaThis study is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of defactinib (VS-6063) in subjects with malignant pleural mesothelioma (MPM) who have not…NCT01870609·San Francisco, California and 72 others

Active not recruitingBiomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary NodulesThis clinical trial studies whether a biomarker platform, the Virtual Nodule Clinic, can be used for the management of lung (pulmonary) nodules that are not clearly non-cancerous…NCT06638398·Aurora, Colorado and 4 others

WithdrawnMechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2This study tests the hypothesis that endogenous bradykinin contributes to effects of a combined angiotensin receptor blocker/neprilysin inhibitor (LCZ696 or Entresto)NCT03005184·Nashville, Tennessee

PreviousPage 100 of 545Next

Diabetes

in Nashville

Heart Diseasein Nashville